½ÃÀ庸°í¼­
»óǰÄÚµå
1631194

ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Medical Imaging Phantoms Market Size, Share & Trends Analysis Report By Product, By Application (Calibration & Quality Assurance, Diagnostic Imaging, R&D), By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, IncÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 2¾ï 5,570¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â ¿¬Æò±Õ 5.9%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø´Ü ¹æ»ç¼±ÇÐÀº ³ú¼Õ»ó, ¾Ï ¹× ±âŸ Áúº´ÀÇ Á¤¹Ð Áø´Ü¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT) ½ºÄµ°ú ÀÚ±â°ø¸í¿µ»ó(MRI)Àº ³Î¸® »ç¿ëµÇ´Â ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆÒÅÒÀº ÀÇ·á Àü¹®°¡°¡ Ä¡·á¿¡ ÇÊ¿äÇÑ Á¤º¸¸¦ °¨Áö, ÇØ¼®, ºÐ¼® ¹× Æò°¡ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ¾î ÀÌ·¯ÇÑ ¿µ»ó ÀåºñÀÇ È¿À²¼ºÀ» ³ôÀÌ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ÁßÁõ ÁúȯÀÇ Áø´Ü¿¡ ÀÌ·¯ÇÑ ÀåÄ¡¸¦ äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ÀÇ·á ¿µ»ó °æÀï ½Ã³ª¸®¿À¿Í ÷´Ü ±â¼ú Á¦°øÀ» À§ÇÑ °æÀïÀÇ Áõ°¡´Â Á¦Ç° äÅÃÀ» ÃËÁøÇÏ´Â ¸î °¡Áö ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ ¹æ»ç¼± ÇÐȸ¿¡ ÁÖ¿ä ±â¾÷µéÀÇ Âü¿©°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÀÌ·¯ÇÑ ÀåÄ¡¿Í °¢ ÆÒÅÒÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÏÀ̺긮µå À̹Ì¡ ÀåÄ¡¿¡ ´ëÇÑ ÀÌ·¯ÇÑ ÆÒÅÒÀÇ È¿´ÉÀ» ÀÌÇØÇϱâ À§ÇÑ ÀüÀÓ»ó ¿¬±¸ÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ¼ºÀå ÀáÀç·ÂÀ» È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

÷´Ü ¼ÒÀç ¹× Á¦Á¶ ±â¼úÀÇ Ã¤ÅÃÀº ƯÁ¤ Áúº´¿¡ ´ëÇÑ ÆÒÅÒÀÇ Àû¿ëÀ» °­È­ÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÷´Ü ½Ã¹Ä·¹ÀÌ¼Ç ÆÒÅÒÀÇ Ã¤ÅÃÀº ¼¼Æ÷ ¼öÁØÀÇ ½ÇÁ¦ ¿ªÇп¡ ´ëÇÑ ±íÀº ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© Áø´ÜÀÇ Á¤È®¼ºÀ» ³ôÀÏ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ÀÌ·¯ÇÑ ÀåÄ¡µéÀº ´Ù¾çÇÑ ÀåÁ¡À» °¡Áö°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Àå±â ¹× Á¶Á÷ÀÇ »ç½ÇÀûÀÎ ÀÇ·á¿ë À̹ÌÁö ÆÒÅÒÀº 3D ±â¼úÀ» »ç¿ëÇÏ¿© ÀÇ·á¿ë ¿µ»ó Áø´Ü ÀåºñÀÇ ¼º´ÉÀ» Çâ»ó½Ã۱â À§ÇØ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ÆÒÅÒÀÌ ½ÃÀåÀ» Àå¾ÇÇÏ¿© 2024³â 30.6%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ±³Á¤ ¹× ǰÁú º¸ÁõÀº Á¤È®ÇÑ ¿µ»ó°ú Áø´ÜÀÇ ½Å·Ú¼ºÀ» À¯ÁöÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÔÀ¸·Î½á 2024³â 38.3%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ï´Ù.
  • º´¿ø ¹× Áø´Ü ¿µ»ó ¼¾ÅͰ¡ 2024³â 56.3%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ºÏ¹Ì ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀåÀº 2024³â 36.4%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

  • Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, Á¦Ç°º°, 2018-2030³â
  • CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ÆÒÅÒ
  • MRI(ÀÚ±â°ø¸í¿µ»ó) ÆÒÅÒ
  • ÃÊÀ½ÆÄ ÆÒÅÒ
  • X¼± ÆÒÅÒ
  • ÇÙÀÇ·á ÆÒÅÒ
  • ±âŸ

Á¦5Àå ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå : ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • ±³Á¤°ú ǰÁú º¸Áõ
  • Áø´Ü ¿µ»ó
  • ¿¬±¸°³¹ß
  • Æ®·¹ÀÌ´×°ú ±³À°
  • Ä¡·á ¿ëµµ

Á¦6Àå ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • º´¿ø°ú Áø´Ü ¿µ»ó ¼¾ÅÍ
  • ÀÇ·á±â±â Á¦Á¶¾÷ü
  • ±âŸ

Á¦7Àå ÀÇ·á¿ë ¿µ»ó ÆÒÅÒ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • Âü¿©ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • BARTEC Top Holding GmbH
    • Gold Standard Phantoms
    • IBA Worldwide
    • Kyoto Kagaku Co., Ltd.
    • Leeds Test Objects
    • Mirion Technologies, Inc.
    • PTW Freiburg GmbH
    • Pure Imaging Phantoms
    • RSD Radiology Support Devices
ksm 25.03.07

Medical Imaging Phantom Market Growth & Trends:

The global medical imaging phantoms market size is estimated to reach USD 255.7 million by 2030, registering to grow at a CAGR of 5.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. Diagnostic radiology is widely adopted for precision diagnosis of brain injuries, cancer, and other diseases. In addition, computed tomography (CT) scan and magnetic resonance imaging (MRI) are widely used techniques. These phantoms help in enhancing the efficiency of these imaging devices by helping medical experts in detecting, interpreting, analyzing, and evaluating information required for treatments. Therefore, the increasing adoption of these devices for the diagnosis of severe diseases is expected to drive the market growth.

Effective reimbursement scenario of medical imaging and growing competition to provide advanced technologies are a few factors driving the adoption of the product. Moreover, the growing participation of key players in various radiology conferences is expected to drive the adoption of these devices and their respective phantoms. The increasing number of preclinical studies to understand the effectiveness of these phantoms for hybrid imaging devices is expected to expand the growth potential in the coming years.

The introduction of advanced materials and production techniques are some of the major factors expected to strengthen the applications of these phantoms for specific diseases. The introduction of advanced simulating phantoms is anticipated to provide deep insights on actual dynamics at a cellular level, thus enhancing the precision in diagnostics.

These devices have various associated advantages, which is a key factor driving the market growth. For instance, realistic medical imaging phantoms of organs and tissues are being developed using 3D technology to enhance the performance of medical imaging devices. This, in turn, is expected to drive the medical imaging phantom market growth over the forecast period.

Medical Imaging Phantom Market Report Highlights:

  • CT (Computed Tomography) phantoms dominated the market and accounted for a share of 30.6% in 2024, driven by their essential function in facilitating accurate calibration and quality assurance of imaging systems.
  • Calibration & quality assurance led the market with a revenue share of 38.3% in 2024, fueled by their crucial role in maintaining accurate imaging and diagnostic reliability.
  • Hospitals & diagnostic imaging centers held the largest market share of 56.3% in 2024, aided by the rising prevalence of chronic diseases and the necessity for accurate diagnostic imaging.
  • North America medical imaging phantoms market dominated the global market with a revenue share of 36.4% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Medical Imaging Phantoms Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Medical Imaging Phantoms Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. CT (Computed Tomography) Phantoms
    • 4.4.1. CT (Computed Tomography) Phantoms Market, 2018 - 2030 (USD Million)
  • 4.5. MRI (Magnetic Resonance Imaging) Phantoms
    • 4.5.1. MRI (Magnetic Resonance Imaging) Phantoms Market, 2018 - 2030 (USD Million)
  • 4.6. Ultrasound Phantoms
    • 4.6.1. Ultrasound Phantoms Market, 2018 - 2030 (USD Million)
  • 4.7. X-ray Phantoms
    • 4.7.1. X-ray Phantoms Market, 2018 - 2030 (USD Million)
  • 4.8. Nuclear Medicine Phantoms
    • 4.8.1. Nuclear Medicine Phantoms Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Medical Imaging Phantoms Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Calibration & Quality Assurance
    • 5.4.1. Calibration & Quality Assurance Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Imaging
    • 5.5.1. Diagnostic Imaging Market, 2018 - 2030 (USD Million)
  • 5.6. Research & Development
    • 5.6.1. Research & Development Market, 2018 - 2030 (USD Million)
  • 5.7. Training & Education
    • 5.7.1. Training & Education Market, 2018 - 2030 (USD Million)
  • 5.8. Therapeutic Applications
    • 5.8.1. Therapeutic Applications Market, 2018 - 2030 (USD Million)

Chapter 6. Medical Imaging Phantoms Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals & Diagnostic Imaging Centers
    • 6.4.1. Hospitals & Diagnostic Imaging Centers Market, 2018 - 2030 (USD Million)
  • 6.5. Medical Device Manufacturers
    • 6.5.1. Medical Device Manufacturers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Medical Imaging Phantoms Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Medical Imaging Phantoms Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Medical Imaging Phantoms Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Medical Imaging Phantoms Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Medical Imaging Phantoms Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Medical Imaging Phantoms Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Medical Imaging Phantoms Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. BARTEC Top Holding GmbH
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Gold Standard Phantoms
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. IBA Worldwide
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Kyoto Kagaku Co., Ltd.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Leeds Test Objects
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Mirion Technologies, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. PTW Freiburg GmbH
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Pure Imaging Phantoms
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. RSD Radiology Support Devices
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦